Home » PRAECIS PHARMACEUTICALS TO SELL FACILITIES FOR ABOUT $51.3 MLN
PRAECIS PHARMACEUTICALS TO SELL FACILITIES FOR ABOUT $51.3 MLN
Praecis Pharmaceuticals Inc. (PRCS.O: Quote, Profile, Research) on Tuesday said it has agreed to sell its corporate headquarters and research facility to Intercontinental Real Estate Corp. for about $51.3 million. Praecis would realize proceeds of about $50.6 million, net of fees and expenses, on close of the transaction which is expected by the end of October, the company said in a news release.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May